2m 2m 2m 2m 2m 2m 2m
UROGEN PHARMA (URGN)
NASDAQ
$38.59+$0.35 (+0.92%)
Price as of Aug 03, 2026 9:03 AM EDT- $1.8BMarket Cap
- 97.11%1-Year Change
- BiotechnologyIndustry
UROGEN PHARMA (URGN)
$38.59+$0.35 (+0.92%)
URGN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $38.24 | ||
Change | -$2.85 (-6.94%) | ||
Open | $41.10 | ||
High | $41.10 | ||
Low | $38.01 | ||
Previous Close | $41.09 | ||
Volume | 814,723 | ||
30-Day Average Volume | 763,658 | ||
1-Week Change | -6.66% | ||
1-Month Change | 3.91% | ||
1-Year Change | 97.11% | ||
3-Year Change | 76.55% | ||
5-Year Change | 146.71% | ||
Fundamentals | |||
Shares Outstanding | 46.8M | ||
Total Assets | $253.7M | ||
Market Cap | $1.8B | ||
Enterprise Value | $1.9B | ||
Period: QTR TTM FY | |||
Revenue | $51.0M | ||
Net Income | -$23.6M | ||
Free Cash Flow | -$45.4M | ||
EBIT | -$28.3M | ||
EBITDA | -$28.3M | ||
Net Working Capital | $186.8M | ||
EPS | -$0.47 | ||
Enterprise Value/EBITDA | -66 | ||
Enterprise Value/Revenue | 37 | ||
P/B | -14 | ||
P/E | -81 | ||
PEG | -7 | ||
Price/Free Cash Flow | -39 | ||
Price/Operating Cash Flow | -39 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue